Skip to content

Clinical Characteristics and Mechanistic Study of New Stricture Subtypes in Stricturing Crohn's Disease

Clinical Characteristics and Mechanistic Study of New Stricture Subtypes in Stricturing Crohn's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117899
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease (CD)

Interventions

CD patients with hypertrophic small bowel strictures requiring surgical treatment:none
CD patients with stricturing small bowel stenosis requiring surgical treatment:none

Sponsors

Wuxi people’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 65 years; 2.Diagnosed with Crohn’s disease (CD) based on the diagnostic criteria outlined in the Chinese Consensus Guidelines for the Diagnosis and Treatment of Crohn’s Disease (2023, Guangzhou), through comprehensive analysis of clinical presentation, laboratory tests, imaging, endoscopic findings, and histopathological features, after excluding infectious and other non-infectious forms of colitis; 3.Presence of small bowel stricture confirmed by clinical presentation, imaging findings, and in accordance with the European Crohn’s and Colitis Organisation (ECCO) guidelines; 4.Indication for surgery according to the 2020 Expert Consensus on Surgical Treatment of Inflammatory Bowel Disease; 5.Scheduled for surgical treatment with availability of intact lesion tissue; the patient has signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Confirmed concurrent active infection (e.g., tuberculosis, CMV, etc.); 2.Concurrent malignancy or other autoimmune diseases; 3.Presence of other severe comorbidities or inability to complete follow-up; 4.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Complete Blood Count, liver and kidney function, Erythrocyte Sedimentation Rate [ESR], C-Reactive Protein [CRP]/high-sensitivity CRP [hsCRP];Imaging features: CT, MRI, intestinal ultrasound;Transcriptome?Whole Genome??Epigenome ?Proteome?Metabolome ?Spatial Transcriptomics;Other Montreal Classification Indicators (Stricture Location, Disease Behavior, Perianal Involvement);

Secondary

MeasureTime frame
Demographic Characteristics;CDAI Score;

Countries

China

Contacts

Public ContactSun Jing

Wuxi people’s Hospital

jingdianjing99@126.com+86 13675151962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026